What is CaNCURE?

CaNCURE was created in 2015 to provide Northeastern University undergrads with experiential training in cancer nanomedicine.  Sixty-six trainees have already completed the program so far, and we expect to train another eighty-nine students in the next 5 years.
Our co-op students spend 6-months performing hands-on research in a NCI-funded research laboratory.   This research experience is supplemented with research and bio/nano innovation seminars, professional development activities, and opportunities to present research.
Our alumni have successfully found new co-op and jobs in cancer research, scholarships to medical school, and scholarships to graduate school.  58% of alumni are currently performing cancer research.

75

Trainees

29

Mentors

31

Publications

118

Presentations


Hear from our Alumni:

“The work that I am doing may one day assist in providing new ways of identifying and monitoring cancer.  This means that physicians could find cancer earlier and provide patients with better treatment options, tailored to their individual disease at that moment in time.  This would improve patient’s prognosis and quality of life, which is the most important thing in the world.”

Rachel Fontana, Biochemistry, ’16


Trainee Spotlight


Mahimasri Kotamreddy

Biology and Mathematics, '21

Understanding the Role of Epigenetics in Multiple Myeloma Progression

Mia Wallach

Business (w Concentration in Healthcare Management and Consulting), '23

Nano-Talazoparib and Nano-Dinaciclib Combination Therapy for Lung Cancer Cells

Kevin Lin

Health Science, '21

Granzyme B Peptide as a Non-invasive Theranostic Agent

Featured Trainee Publication


Upcoming Events

Check back soon for new events


Mentor Spotlight


Wilfred Ngwa, Ph.D.

Assistant Professor of Radiation Oncology,

My work integrates research, clinical service, and teaching in Radiation Oncology, with current focus on developing smart biomaterials (Tiny drones to Target cancer) designed to boost local and metastatic tumor cell kill with minimal collateral damage or side effects.


Mukesh Harisinghani, M.D.

Professor of Radiology,

We develop magnetic nanoparticle-based platforms for use as magnetic resonance imaging (MRI) contrast agents in cancer diagnosis. Students will have the opportunity to study nanoparticle-enhanced MRI data from clinical trials in order to improve the detection of lymph node metastases.


Trainee Spotlight


Marina Yamada

Health Science, '21

Triple-targeted Photonanomedicine: A Strategy to Treat Heterogeneous Tumors

Muskaan Rastogi

Health Science, '21

Monocyte Subtype Determination by Labeling with Feraheme Nanoparticles

Claire Buxton

Molecular Biology, '21

Role of ESRP1/ESRP2 splicing regulators in the development of Triple-Negative Breast Cancer


 Get Involved

Interested in learning how nanomedicine is used to detect and treat cancer? Want to get involved in developing new nanotechnologies for the clinic? We are looking to match undergrads at Northeastern University with leading Boston researchers and clinicians for a six-month, hands-on research experience.  If you are thinking about a career in cancer science, engineering, or medicine, come get involved in the world’s first undergraduate program in cancer nanomedicine!  We have 9 upcoming openings for the January – June 2019 co-op period.  We will be accepting applications starting in September 2018 via NUcareers.

Going on in the lab right now...